Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.42 Trillion Total Companies: 1,736
Total Market Cap (USD)
$1.42 Trillion
Companies Listed
1,736
Largest Company
ADVICENNE (PROM.) EO-20
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1051 |
ADVICENNE (PROM.) EO-20
F:3MM |
$15.55 Million | €15.15 Million | Germany | €1.88 | -0.21% | -0.74% | 59.69K |
| 1052 |
Citius Pharmaceuticals Inc
NASDAQ:CTXR |
$15.53 Million | $15.53 Million | USA | $0.83 | +1.80% | -11.32% | 17.40 Million |
| 1053 |
Lexaria Bioscience Corp
NASDAQ:LEXX |
$15.49 Million | $15.49 Million | USA | $0.75 | +1.78% | +2.34% | 3.23 Million |
| 1054 |
BioLineRx Ltd
NASDAQ:BLRX |
$15.18 Million | $15.18 Million | USA | $2.62 | -3.32% | -1.87% | 223.93K |
| 1055 |
SKINBIO THERAP LS-01
F:5KW |
$15.12 Million | €14.73 Million | Germany | €0.09 | -10.19% | -22.92% | 10.00K |
| 1056 |
Medivir AB (publ)
F:MVR0 |
$15.08 Million | €14.70 Million | Germany | €0.21 | -4.60% | +79.81% | 37.42K |
| 1057 |
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS |
$15.03 Million | $15.03 Million | USA | $6.48 | -0.15% | -16.06% | 17.27 Million |
| 1058 |
Exicure Inc
NASDAQ:XCUR |
$14.99 Million | $14.99 Million | USA | $4.43 | -2.42% | +8.31% | 377.68K |
| 1059 |
Bioleaders Corporation
KQ:142760 |
$14.85 Million | ₩21.75 Billion | Korea | ₩690.00 | +2.22% | +10.75% | 38.22 Million |
| 1060 |
Harvard Apparatus Regenerative Technology Inc.
OTCQB:HRGN |
$14.80 Million | $14.80 Million | USA | $1.80 | +0.00% | -15.29% | 4.77K |
| 1061 |
Daesung Microbiological Labs. Co. Ltd
KQ:036480 |
$14.76 Million | ₩21.61 Billion | Korea | ₩9260.00 | -1.07% | +14.04% | 6.48 Million |
| 1062 |
Hoth Therapeutics Inc
NASDAQ:HOTH |
$14.74 Million | $14.74 Million | USA | $0.99 | -4.81% | -1.49% | 10.34 Million |
| 1063 |
Longeveron LLC
NASDAQ:LGVN |
$14.72 Million | $14.72 Million | USA | $0.98 | +1.69% | +9.56% | 316.65 Million |
| 1064 |
Thiogenesis Therapeutics Corp.
V:TTI |
$14.70 Million | CA$21.11 Million | Canada | CA$0.49 | +3.16% | -16.95% | 447.44K |
| 1065 |
Adaptimmune Therapeutics Plc
NASDAQ:ADAP |
$14.55 Million | $14.55 Million | USA | $0.04 | -29.13% | -50.34% | 2.65 Billion |
| 1066 |
Pharma Equity Group A/S Cl A
CO:PEG |
$14.50 Million | Dkr105.37 Million | Denmark | Dkr0.09 | +6.13% | -4.86% | 6.21 Million |
| 1067 |
IGM BIOSCIENCES DL-01
F:1K0 |
$14.29 Million | €13.92 Million | Germany | €1.08 | +0.93% | -0.92% | 23.00K |
| 1068 |
Kalaris Therapeutics, Inc.
NASDAQ:KLRS |
$13.76 Million | $13.76 Million | USA | $7.53 | -11.62% | -24.40% | 1.40 Million |
| 1069 |
Isofol Medical AB
ST:ISOFOL |
$13.59 Million | Skr152.44 Million | Sweden | Skr0.66 | +0.23% | -4.35% | 72.50 Million |
| 1070 |
Oncotelic Therapeutics Inc
OTCQB:OTLC |
$13.58 Million | $13.58 Million | USA | $0.06 | +20.00% | +0.00% | 1.84 Million |
| 1071 |
NeoCore Technology Co., Ltd.
TWO:4131 |
$13.39 Million | NT$443.06 Million | Taiwan | NT$36.50 | +0.55% | -3.69% | 1.91 Million |
| 1072 |
Skye Bioscience, Inc. Common Stock
NASDAQ:SKYE |
$13.38 Million | $13.38 Million | USA | $0.67 | +0.45% | -15.75% | 22.82 Million |
| 1073 |
4170
TWO:4170 |
$13.35 Million | NT$441.70 Million | Taiwan | NT$13.50 | +0.75% | -4.26% | 1.10 Million |
| 1074 |
Sprint Bioscience AB
ST:SPRINT |
$13.28 Million | Skr149.01 Million | Sweden | Skr2.11 | -0.94% | +10.47% | 20.83 Million |
| 1075 |
09R
F:09R |
$12.96 Million | €12.63 Million | Germany | €0.64 | +16.51% | +3.25% | 45.55K |
| 1076 |
Intervacc AB
ST:IVACC |
$12.95 Million | Skr145.31 Million | Sweden | Skr0.73 | -2.03% | -4.61% | 17.06 Million |
| 1077 |
Neuroscientific Biopharmaceuticals Ltd
AU:NSB |
$12.87 Million | AU$20.78 Million | Australia | AU$0.09 | -5.49% | -14.00% | 5.15 Million |
| 1078 |
Polyrizon Ltd. Ordinary Shares
NASDAQ:PLRZ |
$12.70 Million | $12.70 Million | USA | $14.41 | +5.96% | +11.19% | 841.32K |
| 1079 |
NUTRIBAND INC. DL -001
F:9WV |
$12.59 Million | €12.27 Million | Germany | €3.08 | +2.67% | -8.33% | 18.98K |
| 1080 |
Cellectar Biosciences Inc
NASDAQ:CLRB |
$12.55 Million | $12.55 Million | USA | $3.25 | -1.52% | +6.56% | 1.03 Million |
| 1081 |
LianBio
PINK:LIANY |
$12.55 Million | $12.55 Million | USA | $0.20 | +0.00% | +1.01% | 124.40K |
| 1082 |
UNBSF
PINK:UNBSF |
$12.45 Million | $12.45 Million | USA | $0.00 | +0.00% | +0.00% | 0.00 |
| 1083 |
Bio-Works Technologies AB
ST:BIOWKS |
$12.37 Million | Skr138.77 Million | Sweden | Skr2.87 | -1.37% | +2.50% | 3.21 Million |
| 1084 |
Eusol Biotech Co.,Ltd.
TWO:6652 |
$12.36 Million | NT$409.05 Million | Taiwan | NT$6.10 | +1.67% | -3.17% | 1.35 Million |
| 1085 |
Applied Therapeutics Inc
NASDAQ:APLT |
$12.34 Million | $12.34 Million | USA | $0.10 | +0.00% | +6.96% | 245.46 Million |
| 1086 |
Hookipa Pharma Inc
NASDAQ:HOOK |
$12.33 Million | $12.33 Million | USA | $1.08 | -0.92% | +3.85% | 180.32K |
| 1087 |
Nanogroup SA
WAR:NNG |
$12.30 Million | zł51.16 Million | Poland | zł2.51 | +0.00% | +0.20% | 3.21 Million |
| 1088 |
Initiator Pharma A/S
ST:INIT |
$12.23 Million | Skr137.15 Million | Sweden | Skr3.10 | +0.65% | +6.90% | 1.90 Million |
| 1089 |
AlzeCure Pharma
ST:ALZCUR |
$12.21 Million | Skr136.97 Million | Sweden | Skr1.73 | -2.81% | -6.99% | 1.14 Million |
| 1090 |
SoftOx Solutions AS
OL:SOFTX |
$12.09 Million | Nkr137.71 Million | Norway | Nkr0.07 | -4.34% | +0.86% | 809.37 Million |
| 1091 |
Estrella Immunopharma Inc.
NASDAQ:ESLA |
$11.86 Million | $11.86 Million | USA | $1.08 | -2.70% | -11.48% | 1.07 Million |
| 1092 |
Abliva AB (publ)
PINK:NEVPF |
$11.77 Million | $11.77 Million | USA | $0.01 | +0.00% | +0.00% | 0.00 |
| 1093 |
Argenica Therapeutics Ltd
AU:AGN |
$11.71 Million | AU$18.91 Million | Australia | AU$0.21 | +2.50% | -2.38% | 3.24 Million |
| 1094 |
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD |
$11.67 Million | $11.67 Million | USA | $7.24 | -3.98% | -9.50% | 1.18 Million |
| 1095 |
Soligenix Inc.
NASDAQ:SNGX |
$11.64 Million | $11.64 Million | USA | $1.22 | -3.17% | -0.81% | 3.29 Million |
| 1096 |
Traws Pharma Inc
NASDAQ:TRAW |
$11.63 Million | $11.63 Million | USA | $2.02 | -8.18% | +16.76% | 2.73 Million |
| 1097 |
Medifron DBT Co. Ltd
KQ:065650 |
$11.59 Million | ₩16.97 Billion | Korea | ₩2020.00 | -0.49% | +10.14% | 1.48 Million |
| 1098 |
Holy Stone Healthcare Co., Ltd.
TWO:4194 |
$11.55 Million | NT$382.23 Million | Taiwan | NT$7.09 | -0.56% | -5.84% | 1.83 Million |
| 1099 |
Sensei Biotherapeutics Inc
NASDAQ:SNSE |
$11.47 Million | $11.47 Million | USA | $30.53 | +1.73% | +1.77% | 16.13 Million |
| 1100 |
Pluri Inc.
NASDAQ:PLUR |
$11.28 Million | $11.28 Million | USA | $3.29 | +1.86% | -2.37% | 134.79K |
| 1101 |
Renovaro Biosciences Inc
NASDAQ:RENB |
$11.22 Million | $11.22 Million | USA | $1.13 | -8.87% | -20.42% | 65.34 Million |
| 1102 |
Corline Biomedical AB
ST:CLBIO |
$11.03 Million | Skr123.70 Million | Sweden | Skr15.35 | +1.66% | -3.46% | 386.27K |
| 1103 |
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG |
$11.01 Million | $11.01 Million | USA | $0.26 | -5.68% | -34.23% | 24.57 Million |
| 1104 |
Pieris Pharmaceuticals Inc
NASDAQ:PIRS |
$10.99 Million | $10.99 Million | USA | $13.60 | +0.00% | +0.00% | 51.73K |
| 1105 |
Antibe Therapeutics Inc
PINK:ATBPF |
$10.98 Million | $10.98 Million | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 1106 |
Cell Source Inc
OTCQB:CLCS |
$10.77 Million | $10.77 Million | USA | $0.36 | +0.00% | +7.08% | 71.23K |
| 1107 |
Neurosense Therapeutics Ltd
NASDAQ:NRSN |
$10.66 Million | $10.66 Million | USA | $0.77 | -5.36% | -10.80% | 4.50 Million |
| 1108 |
BALAXI PHARMACEUTICALS LIMITED
NSE:BALAXI |
$10.61 Million | ₹918.47 Million | India | ₹17.94 | +1.36% | -3.96% | 3.11 Million |
| 1109 |
Rapid Dose Therapeutics Corp
PINK:RDTCF |
$10.60 Million | $10.60 Million | USA | $0.18 | +0.00% | +0.00% | 0.00 |
| 1110 |
Zeo ScientifiX, Inc.
OTCQB:ZEOX |
$10.59 Million | $10.59 Million | USA | $2.65 | +11.81% | +1.92% | 13.30K |
| 1111 |
Biovie Inc
NASDAQ:BIVI |
$10.58 Million | $10.58 Million | USA | $1.41 | +0.71% | +2.92% | 2.17 Million |
| 1112 |
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM |
$10.57 Million | $10.57 Million | USA | $19.50 | +0.00% | -2.11% | 164.58K |
| 1113 |
Hemostemix Inc
OTCQB:HMTXF |
$10.45 Million | $10.45 Million | USA | $0.07 | +5.56% | -4.49% | 133.25K |
| 1114 |
Bonus BioGroup Ltd
PINK:BBIXF |
$10.35 Million | $10.35 Million | USA | $0.03 | +0.00% | +0.00% | 4.90K |
| 1115 |
APTAMER GROUP LTD LS-001
F:P0J |
$10.34 Million | €10.07 Million | Germany | €0.01 | +0.00% | -6.67% | 170.90K |
| 1116 |
Cocrystal Pharma Inc
NASDAQ:COCP |
$10.31 Million | $10.31 Million | USA | $1.13 | +1.80% | +6.10% | 1.04 Million |
| 1117 |
Biomind Labs Inc.
PINK:BMNDF |
$10.18 Million | $10.18 Million | USA | $0.70 | +0.00% | +0.00% | 0.00 |
| 1118 |
Lukas Biomedical Inc.
TWO:6814 |
$10.13 Million | NT$335.21 Million | Taiwan | NT$26.75 | +0.94% | -0.19% | 381.51K |
| 1119 |
Poxel SA
PA:POXEL |
$10.04 Million | €9.78 Million | France | €0.25 | -0.60% | -3.29% | 4.07 Million |
| 1120 |
SOFTOX SOLUTIONS NK 002
F:6FV |
$10.00 Million | €9.74 Million | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1121 |
Algorae Pharmaceuticals Ltd
AU:1AI |
$9.99 Million | AU$16.14 Million | Australia | AU$0.02 | +0.00% | +15.38% | 31.30 Million |
| 1122 |
Elicera Therapeutics AB
ST:ELIC |
$9.98 Million | Skr111.97 Million | Sweden | Skr5.41 | +2.08% | -6.40% | 6.83 Million |
| 1123 |
IRLAB THERAP. AB A
F:6IRA |
$9.98 Million | €9.72 Million | Germany | €0.15 | +3.71% | -1.63% | 0.00 |
| 1124 |
2BO
F:2BO |
$9.80 Million | €9.55 Million | Germany | €1.84 | +57.26% | +49.59% | 21.00 |
| 1125 |
NextCell Pharma AB
ST:NXTCL |
$9.63 Million | Skr108.02 Million | Sweden | Skr1.29 | +5.93% | +0.47% | 6.27 Million |
| 1126 |
SMS Lifesciences India Limited
NSE:SMSLIFE |
$9.61 Million | ₹831.94 Million | India | ₹1288.50 | -6.64% | -3.37% | 65.05K |
| 1127 |
IRLAB Therapeutics AB (publ)
ST:IRLAB-A |
$9.59 Million | Skr107.57 Million | Sweden | Skr1.60 | +0.38% | -2.56% | 6.91 Million |
| 1128 |
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS |
$9.55 Million | $9.55 Million | USA | $18.28 | -4.94% | -3.69% | 5.24 Million |
| 1129 |
Orgenesis Inc
OTCQB:ORGS |
$9.54 Million | $9.54 Million | USA | $2.52 | -2.33% | -21.25% | 90.02K |
| 1130 |
BenevolentAI SA
AS:BAI |
$9.51 Million | €9.27 Million | Netherlands | €0.08 | +0.00% | +0.00% | 712.33K |
| 1131 |
ABERA BIOSCIENCE AB
F:8WK |
$9.50 Million | €9.26 Million | Germany | €0.53 | -2.75% | +4.95% | 800.00 |
| 1132 |
Senti Biosciences Inc
NASDAQ:SNTI |
$9.43 Million | $9.43 Million | USA | $0.97 | -0.99% | -2.32% | 2.96 Million |
| 1133 |
AEON Biopharma, Inc.
NYSE MKT:AEON |
$9.34 Million | $9.34 Million | USA | $1.14 | -1.72% | +6.54% | 1.89 Million |
| 1134 |
Vimedimex Medi Pharma JSC
VN:VMD |
$9.34 Million | ₫237.33 Billion | Vietnam | ₫16300.00 | -1.21% | -21.26% | 1.09 Million |
| 1135 |
MedMira Inc
PINK:MMIRF |
$9.28 Million | $9.28 Million | USA | $0.07 | +0.00% | +470.23% | 1.70K |
| 1136 |
2H0
F:2H0 |
$9.20 Million | €8.96 Million | Germany | €3.76 | -0.53% | +16.77% | 2.16K |
| 1137 |
Iterum Therapeutics PLC
NASDAQ:ITRM |
$9.18 Million | $9.18 Million | USA | $0.18 | +2.16% | -3.68% | 28.12 Million |
| 1138 |
Lyka Labs Limited
NSE:LYKALABS |
$9.05 Million | ₹783.34 Million | India | ₹54.82 | +6.28% | -2.97% | 1.38 Million |
| 1139 |
Curis Inc
NASDAQ:CRIS |
$8.91 Million | $8.91 Million | USA | $0.82 | -8.58% | -19.30% | 2.94 Million |
| 1140 |
Chromocell Therapeutics Corporation
NYSE MKT:CHRO |
$8.90 Million | $8.90 Million | USA | $22.46 | -5.03% | -0.18% | 214.56K |
| 1141 |
Biotechnology Assets S.A.
MC:BST |
$8.89 Million | €8.66 Million | Spain | €0.24 | +5.36% | +10.28% | 9.89 Million |
| 1142 |
Pharmala Biotech Holdings Inc
OTCQB:MDXXF |
$8.89 Million | $8.89 Million | USA | $0.12 | +3.63% | -3.22% | 75.74K |
| 1143 |
Biocardia Inc
NASDAQ:BCDA |
$8.86 Million | $8.86 Million | USA | $1.23 | -3.91% | -3.15% | 1.71 Million |
| 1144 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
$8.86 Million | $8.86 Million | USA | $4.70 | -7.30% | -11.32% | 9.14 Million |
| 1145 |
NFL Biosciences SAS
PA:ALNFL |
$8.85 Million | €8.62 Million | France | €1.06 | -0.56% | -0.75% | 1.19 Million |
| 1146 |
Addex Therapeutics Ltd
NASDAQ:ADXN |
$8.83 Million | $8.83 Million | USA | $5.90 | -14.24% | -17.71% | 68.42K |
| 1147 |
Noxopharm Limited
PINK:NOXOF |
$8.80 Million | $8.80 Million | USA | $0.05 | +0.00% | +0.00% | 0.00 |
| 1148 |
COCRYSTAL PHARMA NEW O.N.
F:8CC |
$8.77 Million | €8.55 Million | Germany | €0.94 | +2.75% | +9.36% | 47.92K |
| 1149 |
Edesa Biotech Inc
NASDAQ:EDSA |
$8.75 Million | $8.75 Million | USA | $7.69 | +9.86% | +11.45% | 251.05 Million |
| 1150 |
Ikena Oncology Inc
NASDAQ:IKNA |
$8.74 Million | $8.74 Million | USA | $1.43 | +4.38% | +13.49% | 8.91 Million |
| 1151 |
Mendus AB (publ)
ST:IMMU |
$8.66 Million | Skr97.19 Million | Sweden | Skr4.05 | -2.41% | -0.86% | 696.09K |
| 1152 |
Quantum BioPharma Ltd.
NASDAQ:QNTM |
$8.59 Million | $8.59 Million | USA | $2.40 | +0.21% | -14.29% | 5.49 Million |
| 1153 |
Allovir Inc
NASDAQ:ALVR |
$8.56 Million | $8.56 Million | USA | $9.81 | +0.00% | +0.00% | 9.43K |
| 1154 |
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN |
$8.50 Million | $8.50 Million | USA | $1.26 | -59.35% | -72.31% | 27.78 Million |
| 1155 |
SeaStar Medical Holding Corporation
NASDAQ:ICU |
$8.37 Million | $8.37 Million | USA | $2.35 | -5.24% | -12.64% | 1.34 Million |
| 1156 |
NFL BIOSCIENCES EO -03
F:82F |
$8.35 Million | €8.13 Million | Germany | €1.00 | +0.90% | +3.19% | 92.19K |
| 1157 |
Magle Chemoswed Holding Ab
ST:MAGLE |
$8.28 Million | Skr92.92 Million | Sweden | Skr7.85 | +0.64% | +0.64% | 80.16K |
| 1158 |
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI |
$8.28 Million | $8.28 Million | USA | $0.83 | -1.19% | +18.57% | 688.55K |
| 1159 |
Cara Therapeutic
NASDAQ:CARA |
$8.11 Million | $8.11 Million | USA | $18.25 | +243.02% | +276.26% | 656.28K |
| 1160 |
Cambium Bio Ltd
AU:CMB |
$8.11 Million | AU$13.09 Million | Australia | AU$0.48 | +0.00% | -2.04% | 374.47K |
| 1161 |
Imunon Inc
NASDAQ:IMNN |
$8.09 Million | $8.09 Million | USA | $2.97 | -1.00% | -3.88% | 472.78K |
| 1162 |
Synaptogenix Inc
NASDAQ:SNPX |
$8.04 Million | $8.04 Million | USA | $5.82 | -11.08% | -9.77% | 6.42 Million |
| 1163 |
Transcode Therapeutics Inc
NASDAQ:RNAZ |
$7.95 Million | $7.95 Million | USA | $9.55 | -1.34% | -1.14% | 346.21K |
| 1164 |
Bolt Biotherapeutics
NASDAQ:BOLT |
$7.93 Million | $7.93 Million | USA | $4.64 | +4.39% | +8.80% | 599.62K |
| 1165 |
Lipum AB
ST:LIPUM |
$7.90 Million | Skr88.63 Million | Sweden | Skr14.35 | +0.70% | +1.77% | 1.28 Million |
| 1166 |
NKGen Biotech, Inc. Common Stock
PINK:NKGN |
$7.84 Million | $7.84 Million | USA | $0.16 | -6.02% | -8.77% | 1.96 Million |
| 1167 |
Bioatla Inc
NASDAQ:BCAB |
$7.68 Million | $7.68 Million | USA | $0.16 | -8.83% | -7.03% | 43.82 Million |
| 1168 |
Xbrane Biopharma AB
ST:XBRANE |
$7.64 Million | Skr85.69 Million | Sweden | Skr5.70 | +0.78% | -5.00% | 1.61 Million |
| 1169 |
PROBIOTIX HEALTH LS-05
F:X90 |
$7.59 Million | €7.40 Million | Germany | €0.06 | +0.00% | +0.00% | 39.92K |
| 1170 |
Athira Pharma Inc
NASDAQ:ATHA |
$7.52 Million | $7.52 Million | USA | $7.66 | +10.85% | +25.78% | 1.34 Million |
| 1171 |
Pulmatrix Inc
NASDAQ:PULM |
$7.51 Million | $7.51 Million | USA | $2.07 | -1.90% | -7.17% | 1.05 Million |
| 1172 |
Bicycle Therapeutics plc
F:50BA |
$7.47 Million | €7.27 Million | Germany | €3.86 | -11.06% | -11.87% | 400.00 |
| 1173 |
SynCore Biotechnology Co Ltd
TWO:4192 |
$7.44 Million | NT$246.15 Million | Taiwan | NT$20.50 | -1.91% | +1.99% | 337.23K |
| 1174 |
CalciMedica, Inc. Common Stock
NASDAQ:CALC |
$7.40 Million | $7.40 Million | USA | $0.82 | -1.33% | +21.84% | 11.88 Million |
| 1175 |
Kairos Pharma, Ltd.
NYSE MKT:KAPA |
$7.38 Million | $7.38 Million | USA | $0.62 | +2.33% | +11.92% | 26.27 Million |
| 1176 |
Zenith Capital Corp
PINK:ZHCLF |
$7.38 Million | $7.38 Million | USA | $0.05 | +0.00% | +49900.00% | 4.32K |
| 1177 |
Kiora Pharmaceuticals Inc
NASDAQ:KPRX |
$7.37 Million | $7.37 Million | USA | $2.07 | -1.43% | -5.05% | 568.03K |
| 1178 |
Neurotech International Ltd
AU:NTI |
$7.34 Million | AU$11.85 Million | Australia | AU$0.01 | +0.00% | +9.09% | 26.42 Million |
| 1179 |
Evogene
NASDAQ:EVGN |
$7.32 Million | $7.32 Million | USA | $0.85 | -2.77% | +7.32% | 3.29 Million |
| 1180 |
Alzamend Neuro Inc
NASDAQ:ALZN |
$7.28 Million | $7.28 Million | USA | $1.92 | +3.23% | -10.28% | 2.71 Million |
| 1181 |
EZZ Life Science Holdings Ltd
AU:EZZ |
$7.27 Million | AU$11.74 Million | Australia | AU$0.88 | -6.88% | -16.98% | 757.66K |
| 1182 |
Noxopharm Ltd
AU:NOX |
$7.24 Million | AU$11.70 Million | Australia | AU$0.06 | -4.69% | +7.02% | 1.58 Million |
| 1183 |
IO Biotech Inc
NASDAQ:IOBT |
$7.22 Million | $7.22 Million | USA | $0.18 | +4.80% | -30.97% | 37.85 Million |
| 1184 |
Briacell Therapeutics Corp
NASDAQ:BCTX |
$7.18 Million | $7.18 Million | USA | $4.31 | -5.27% | +13.12% | 5.43 Million |
| 1185 |
Aqua Bio Technology ASA
OL:ABTEC |
$7.08 Million | Nkr80.69 Million | Norway | Nkr6.80 | -1.31% | -11.34% | 7.03 Million |
| 1186 |
Xintela AB
ST:XINT |
$7.06 Million | Skr79.25 Million | Sweden | Skr0.24 | -1.26% | +0.00% | 8.42 Million |
| 1187 |
373110
KQ:373110 |
$7.05 Million | ₩10.32 Billion | Korea | ₩1455.00 | -3.13% | +2.83% | 5.64 Million |
| 1188 |
Dextech Medical AB
F:LQ0 |
$6.95 Million | €6.77 Million | Germany | €0.90 | -1.64% | -3.23% | 0.00 |
| 1189 |
In8bio Inc
NASDAQ:INAB |
$6.90 Million | $6.90 Million | USA | $1.84 | -3.66% | +1.66% | 970.94K |
| 1190 |
Phio Pharmaceuticals Corp
NASDAQ:PHIO |
$6.81 Million | $6.81 Million | USA | $1.20 | -5.51% | -2.44% | 43.68 Million |
| 1191 |
Adbiotech Co. Ltd.
KQ:179530 |
$6.81 Million | ₩9.97 Billion | Korea | ₩1750.00 | -0.40% | +18.24% | 6.16 Million |
| 1192 |
Purple Biotech
NASDAQ:PPBT |
$6.77 Million | $6.77 Million | USA | $3.81 | -4.51% | -9.72% | 1.28 Million |
| 1193 |
OPTIBIOTIX HLTH PLC LS-02
F:OB3 |
$6.72 Million | €6.54 Million | Germany | €0.07 | -0.70% | +11.02% | 58.10K |
| 1194 |
Celyad Oncology SA
PINK:CLYYF |
$6.71 Million | $6.71 Million | USA | $0.65 | +0.00% | +0.00% | 0.00 |
| 1195 |
ESSA Pharma Inc
NASDAQ:EPIX |
$6.71 Million | $6.71 Million | USA | $0.20 | -1.85% | +5.34% | 77.22 Million |
| 1196 |
PharmaCyte Biotech Inc
NASDAQ:PMCB |
$6.58 Million | $6.58 Million | USA | $0.70 | +1.45% | +2.94% | 2.75 Million |
| 1197 |
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA |
$6.50 Million | $6.50 Million | USA | $3.68 | -7.31% | -12.38% | 74.17 Million |
| 1198 |
Processa Pharmaceuticals Inc
NASDAQ:PCSA |
$6.45 Million | $6.45 Million | USA | $3.16 | +0.00% | +8.22% | 802.86K |
| 1199 |
Curative Biotechnology Inc
NYSE MKT:CUBT |
$6.44 Million | $6.44 Million | USA | $0.01 | -7.41% | -8.54% | 1.98 Million |
| 1200 |
ACTICOR BIOTECH EO 1
F:7V7 |
$6.36 Million | €6.20 Million | Germany | €0.75 | +0.00% | +0.00% | 0.00 |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries